Pearlman Cancer Center Named Leading Business

The Valdosta-Lowndes Chamber of Commerce recognized the medical facility for its regional healthcare contributions.

Updated on Oct. 10, 2026 in Cancer

Bold vector editorial illustration of a modern medical facility facade with geometric sunshades, representing professional regional healthcare.
The Valdosta-Lowndes Chamber of Commerce named SGMC Health Pearlman Cancer Center its Leading Business of the Week for expanded oncology services. AI Illustration. Upload story photo >

The Valdosta-Lowndes Chamber of Commerce selected SGMC Health Pearlman Cancer Center as its Leading Business of the Week. The center provides comprehensive cancer care services to residents across South Georgia and North Florida.

Why it matters

The recognition highlights the center's role in expanding specialized medical access for the local community. It specifically acknowledges the facility's commitment to delivering advanced oncology services to a broad regional patient base.

Located at 209 Pendleton Drive, the facility has served the region since 1995. Its service model includes medical oncology, radiation therapy, and specialized genetic services.

The players

SGMC Health Pearlman Cancer Center

This medical facility provides specialized oncology and radiation treatment services to patients in South Georgia and North Florida.

Valdosta-Lowndes Chamber of Commerce

This organization represents local business interests and promotes regional economic and community development in Valdosta.

The details

The facility offers a range of treatments, including infusion therapy and clinical trials. Over the past year, the center has expanded its capabilities by introducing Jelmyto therapy and a new treatment plan for patients with sickle cell disease.

Timeline

  1. The center first opened its doors in 1995.

  2. Jelmyto therapy and sickle cell services were introduced between 2025 and 2026.

  3. The chamber designated the center as Leading Business of the Week on October 9, 2026.

The Big Picture

This story follows the community-based clinical integration model established by the National Cancer Institute's community oncology research program framework.

Patients can access an expanded suite of treatments, including newly added sickle cell disease management and Jelmyto therapy. The center expects to further enhance its offerings with the future introduction of scalp cooling and BiTE therapies.

The takeaway

Recognized businesses in the healthcare sector often serve as vital anchors for regional patient navigation and treatment planning. Residents are encouraged to consult their providers regarding the latest therapeutic options available at the facility.

Further reading

Learn more about the latest developments in Cancer care and research.

Source note: This article includes information reported by Valdosta Daily Times.